abrdn Healthcare Investors (HQH) is an CEF managed by abrdn / Aberdeen. Its largest position is Vaxcyte, Inc. (PCVX), representing 3.10% of fund assets.
abrdn Healthcare Investors Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- HQH
- Type:
- CEF
- Manager:
- abrdn / Aberdeen
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 29, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
Vaxcyte, Inc.
|
3.10% | $35,276,547.15 | 607,065 |
|
-
UNIQURE NV
|
3.01% | $34,237,537.65 | 2,094,039 |
|
-
AMGEN INC
|
2.53% | $28,710,256.30 | 81,598 |
|
-
INSMED Inc
|
2.36% | $26,845,568.96 | 164,173 |
|
-
ARGENX SE
|
2.34% | $26,636,599.00 | 36,476 |
|
-
Tectonic Therapeutic, Inc.
|
2.10% | $23,829,755.40 | 770,940 |
|
-
Denali Therapeutics Inc.
|
2.01% | $22,842,816.00 | 1,189,730 |
|
-
Xenon Pharmaceuticals Inc.
|
1.99% | $22,656,461.15 | 389,621 |
|
-
Veradermics, Inc
|
1.92% | $21,830,449.80 | 345,692 |
|
-
Praxis Precision Medicines, Inc.
|
1.81% | $20,548,956.01 | 63,779 |
|
-
Sarepta Therapeutics, Inc.
|
1.80% | $20,488,345.60 | 941,560 |
|
-
BIOCRYST PHARMACEUTICALS INC
|
1.74% | $19,838,927.92 | 2,083,921 |
|
-
ABBOTT LABORATORIES
|
1.70% | $19,340,461.25 | 188,375 |
|
-
CRINETICS PHARMACEUTICALS INC
|
1.62% | $18,459,349.44 | 508,242 |
|
-
Immunovant, Inc.
|
1.57% | $17,866,517.76 | 719,264 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
1.57% | $17,862,664.16 | 23,119 |
|
-
CYTOKINETICS INC
|
1.55% | $17,673,898.32 | 268,152 |
|
-
NEUROVANCE MILESTONE INTEREST
|
1.45% | $16,488,109.07 | 49,006 |
|
-
DANAHER CORP /DE/
|
1.43% | $16,203,784.80 | 85,463 |
|
-
Sionna Therapeutics, Inc.
|
1.40% | $15,880,611.16 | 396,124 |
|
-
Veradermics, Inc
|
1.39% | $15,777,332.85 | 249,839 |
|
-
Oculis Holding AG
|
1.36% | $15,409,862.24 | 579,536 |
|
-
Edgewise Therapeutics, Inc.
|
1.31% | $14,898,964.50 | 472,983 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
1.28% | $14,557,287.39 | 43,997 |
|
-
EyePoint, Inc.
|
1.27% | $14,467,387.97 | 1,122,373 |
|
-
Jazz Pharmaceuticals plc
|
1.27% | $14,411,470.55 | 76,231 |
|
-
INTUITIVE SURGICAL INC
|
1.23% | $13,941,720.57 | 30,243 |
|
-
Merck & Co., Inc.
|
1.22% | $13,842,010.88 | 115,072 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
1.22% | $13,838,328.90 | 220,707 |
|
-
Zoetis Inc.
|
1.20% | $13,649,590.49 | 115,469 |
|
-
Personalis, Inc.
|
1.15% | $13,106,389.66 | 2,057,518 |
|
-
Axsome Therapeutics, Inc.
|
1.13% | $12,835,716.84 | 75,942 |
|
-
ARS Pharmaceuticals, Inc.
|
1.09% | $12,430,552.42 | 1,548,014 |
|
-
Dyne Therapeutics, Inc.
|
1.06% | $12,082,285.25 | 666,425 |
|
-
IDEAYA Biosciences, Inc.
|
0.98% | $11,162,866.40 | 335,020 |
|
-
THERMO FISHER SCIENTIFIC INC.
|
0.97% | $10,983,237.85 | 22,345 |
|
-
NEWAMSTERDAM PHARMA CO NV
|
0.96% | $10,937,977.05 | 341,705 |
|
-
Travere Therapeutics, Inc.
|
0.92% | $10,494,582.14 | 353,234 |
|
-
Elevance Health, Inc.
|
0.90% | $10,189,456.50 | 34,806 |
|
-
CURASEN THERAPEUTICS, INC.
|
0.89% | $10,124,534.13 | 21,114,774 |
|
-
INSULET CORP
|
0.88% | $9,998,876.00 | 47,650 |
|
-
Abivax S.A.
|
0.87% | $9,873,961.25 | 88,675 |
|
-
IMMUNIC, INC.
|
0.86% | $9,820,683.93 | 8,847,463 |
|
-
Inspire Medical Systems, Inc.
|
0.86% | $9,740,057.72 | 188,834 |
|
-
Vericel Corp
|
0.84% | $9,518,491.77 | 295,881 |
|
-
Adaptive Biotechnologies Corp
|
0.82% | $9,378,133.04 | 675,658 |
|
-
Medtronic plc
|
0.81% | $9,257,079.45 | 106,833 |
|
-
CODEXIS, INC.
|
0.80% | $9,111,856.48 | 5,590,096 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
0.78% | $8,919,189.96 | 19,974 |
|
-
Jade Biosciences, Inc.
|
0.73% | $8,285,692.45 | 589,729 |
Advertisement (320x50)